or
forgot password

    • cancer clinical trials in chattanooga, TN

    • Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma
    Sarah Cannon Research Institute SC - 2
    Chattanooga, Tennessee 37404
    Follicular Lymphoma
    A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
    Chattanooga Medical Research, LLC

    Trial Locations
    Chattanooga Medical Research, LLC
    OB-GYN Centre of Excellence
    Urinary Bladder, Overactive
    Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
    Local Institution
    Chattanooga, Tennessee
    Crohn's Disease
    Efficacy Study of Maintenance Therapy for Ovarian Cancer Patients
    Chattanooga GYN Oncology
    Chattanooga, Tennessee 37403
    Cancer, Ovarian Cancer, Solid Tumor
    Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
    Sarah Cannon Research Institute SC - 2
    Chattanooga, Tennessee 37404
    Metastatic or Unresectable Cutaneous Melanoma
    Study With Lead-in Cohort of 5-FU, Oxaliplatin, Lapatinib & 5-FU for Patients With HER2 Positive Esophagogastric Cancer
    Chattanooga Oncology and Hematology Associates
    Chattanooga, Tennessee 37404
    Localized HER2 Positive Esophagogastric Cancer